December 4, 2025Cancer Epidemiology Biomarkers & Prevention

Pharmacogenomics of Breast, Cervical, and Prostate Cancers and CYP2B6 Variants in African Populati

View Full Paper

Ask AI

Bookmark

Authors

OAOluwaferanmi AlufaUniversity of Ibadan OAOlusola AgbanaUniversity of Ibadan JCJames ChiborUniversity of Ibadan

Discussion

Member takes

Implication

Observational analysis shows elevated CYP2B6 variants affecting chemotherapy in African populations, suggesting needed genomic research for treatment improvements.

Key Points

Cyclophosphamide half-life increased with CYP2B6 presence, impacting overall survival for patients.
The study included genetic assessments of 1,371 individuals from both African and European regions.
Analysis utilized Pharmacogenomic Knowledgebase to identify relevant SNP variants among populations studied.
Highlights importance of tailored cancer treatments in Africa based on CYP variants for better outcomes.

Cite This Study

Alufa et al. (2025) studied this question.

synapsesocial.com/papers/6930dc81ea1aef094cca2451 https://doi.org/10.1158/1538-7755.asgcr25-abstract-23

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis shows elevated CYP2B6 variants affecting chemotherapy in African populations, suggesting needed genomic research for treatment improvements.

Pharmacogenomics of Breast, Cervical, and Prostate Cancers and CYP2B6 Variants in African Populati

Discussion

Member takes

Implication

Key Points

Cite This Study

Pharmacogenomics of Breast, Cervical, and Prostate Cancers and CYP2B6 Variants in African Populati

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider